In HNSCC cells, the function of ATAD3A is dependent on its ATP-binding ability and is enabled by a novel regulatory mechanism in which it activates mitochondrial ERK1/2 via protein-protein interaction. The gene discussed is MAPK3; the disease is head and neck squamous cell carcinoma.